Cargando…
Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
CONTEXT: Male hypogonadism adversely affects body composition, bone mineral density (BMD), and metabolic health. A previous report showed that pre-treatment testosterone (T) levels of <200 ng/dl is associated with greater improvement in spine BMD with T therapy. However, to date, there is no stud...
Autores principales: | Deepika, FNU, Ballato, Elliot, Colleluori, Georgia, Aguirre, Lina, Chen, Rui, Qualls, Clifford, Villareal, Dennis T., Armamento-Villareal, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309506/ https://www.ncbi.nlm.nih.gov/pubmed/35898448 http://dx.doi.org/10.3389/fendo.2022.915309 |
Ejemplares similares
-
OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022) -
OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023) -
Adipocytes ESR1 Expression, Body Fat and Response to Testosterone Therapy in Hypogonadal Men Vary According to Estradiol Levels
por: Colleluori, Georgia, et al.
Publicado: (2018) -
Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa, et al.
Publicado: (2021) -
Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)